In the 21 st century the major expenditure for health services worldwide is on chronic, non-communicable disease and the disabling sequelae of acute illness, with its attendant multi-morbidity and incapacity. Persistent illness and disability also present the greatest challenges to effective service design. Successful care requires services to couple responsiveness to unavoidable acute on chronic deterioration with long-term, continuous efforts to prevent avoidable further complications and maximise quality of life. These approaches require different skills. The evidence 1 is clear that in chronic, symptomatic illness a psychologicallyinformed approach is necessary to inform and motivate people to change established beliefs and habits, giving themselves the greatest chance of the best possible physical and psychological health in the longer term. This impact is going to be greatest in those overcoming the greatest disease burden, at the youngest age, to contain accumulating morbidity on morbidity.
There are frequent policy restatements regretting that hospitals are still only designed to meet the needs of those with acute conditions where life-saving treatment or single interventions are required, but not suited to managing chronicity: little changes. The significant advances in the effective acute medical management of myocardial infarction, stroke, and chronic respiratory illness, the care of trauma patients, and the transition of cancer to a chronic illness for many, are impressive achievements. Sadly the quality of survival of people with chronic, progressive disease does not yet reliably match the standard of their acute care, with increasing evidence 2 in the literature of hidden distress and blighted lives for both patient and family. It is clear that continuing symptoms, and chronic maladaptive (if apparently logical) responses to difficult physical and physiological states, if poorly managed over a long period, have a high risk of laying down a foundation of profound disability and then 'frailty' in later years or as a disease advances.
It should follow that the relief of complex symptoms in those with chronic progressive disease and a rehabilitative approach to 'add life to years' would be a major priority of health care services. As there is accumulating evidence that palliative care services help to promote a better quality of life, even prolong it, in patients with non-malignant disease as well as cancer, 3, 4 there should be growing interest in funding and supporting this area of practice. Currently, the opposite is true, with palliative care services across the world under financial pressure.
In study after study, a lack of access to palliative care or a failure of appropriate response of palliative care services for people with severe symptoms in non-malignant disease are described, in spite of the stated aims of our speciality to meet the needs of patients without regard to their diagnosis. We seem to be bystanders in the greatest challenges facing health services across the world, content to step in at the last hours or weeks of a person's life, when decisions about methods of symptom control are much easier. However the greatest period of suffering for people with non-malignant disease may have already passed at this stage, and with it perhaps also our greatest opportunities as a specialty for reducing suffering.
These issues and the particular lack of care for younger people with chronic non-malignant disease were recently highlighted at a seminar at the Royal College of Physicians (Edinburgh). The needs of younger people with a symptomatic, rare chronic respiratory illness were presented and discussed with a multi-professional audience from palliative care services in Lothian. The issues raised act as an exemplar of more general concerns, highlighting the particular difficulties faced by younger adults with non-malignant illness in gaining access to palliative care's evidence-informed symptom control and models of care. These, we know, have the potential to improve the lives of people living with chronic, progressive non-malignant disease.
Gill Hollis presented on behalf of people with LAM (lymphangioleiomyomatosis) 5 . More details of living with this condition and its consequences are eloquently described in a prize-winning autobiographical account 'Illness' by the philosopher Havi Carel 6 . This rare, progressive disease affects young adult women (peak onset in the thirties), and follows a variable course: sometimes rapidly progressive to death, sometimes chronic with peaks and troughs of intrusion into normal, active life. Lung transplant can be a successful therapy for some, but patients are often extremely ill and very symptomatic before it can be offered and some residual difficulties persist in the longer term. LAM is potentially extremely disabling, with the primary symptom being breathlessness, but it is also an 'invisible chronic illness.' 7 . Recent advances Rhetoric and reality -matching palliative care services to meet the needs of patients of all ages, with any diagnosis have led to treatment which slows disease progression for many, but the spectres of uncertainty and fear stalk many patients, with consequent depression and anxiety. Specialist centres for management, as in the UK, where sufferers are seen intermittently, greatly improves outcomes and builds support networks. However, like others with rare debilitating conditions, most care must be given nearer home by generic medical services, in which setting day-to-day psychosocial needs and symptom control are often overlooked. This is where palliative care services could play their part in supporting colleagues who review these individuals, helping patients to live as best they can with severe breathlessness, psychological distress, isolation and a range of other symptoms.
It was clear that across the UK (and worldwide), no matter what their symptom burden, women living with LAM were not being offered palliative care. Moreover, many individual requests for referral to services such as pulmonary rehabilitation were being refused because funding limitations restricted access to sufferers of common diseases such as COPD. This fits the other overwhelming evidence that people with troubling symptoms from chronic non-malignant disease are much less likely to be seen by palliative care services, or receive any level of symptom control from anyone else, and that access is particularly difficult for those too old to access teenage services but younger than most patients receiving palliative care. Many palliative care services offered are framed round the precepts that people with serious illness are no longer in work, do not aspire to work or hold any other longer term ambitions and do not care for young children. This leads to inappropriate suggestions for care or even for equipment e.g. difficulties accessing portable oxygen. Many other illnesses, like LAM, are invisible. As well as excellent symptom control, psychosocial support needs to be geared around the difficulties of living at a younger age with invisible impairment.
Fortunately there has been a recent growing interest in chronic breathlessness and the experience is generally well described, with promising treatment approaches which may build general health as well as reducing symptom burden. 3, 8 The exception is in this group of young adults, whose health was normal before the onset of illness. In addition to the burdens of LAM, they suffer an acute feeling of loss for their former good health, and of being out of step and then alienated from their peer group. Such experiences are different from those who become unwell at the same age as many of their friends or following many years of impairment, and it is mostly unexplored scientifically. For example, Hollis challenged the use of 'breathlessness' as the word best suited to replace the word dyspnoea in discussions with patients: her associations with breathlessness were those of the completely healthy person, exhilaration and a sense of agency that is cruelly, rapidly lost by women with LAM, ILD and other young people.
During the general discussion it was clear that one mismatch between palliative care clinicians and younger patients may result from the clinicians' fear that they would be practising a 'sleight of hand' if they did not confront the possibility of death, and the individual's feelings towards this, as a requirement of palliative care services' professional involvement with a patient. These conversations can alienate younger adults living with potentially life-threatening chronic disease who still want attempts at life-prolonging treatment. Clearly the discussion is needed where death is highly probable or difficult treatment decisions imminent but it should not be a 'tick box' requirement at an early meeting. Prioritising 'advance care planning' over an understanding of the patient's own priorities and their need for symptom control both frightens the patient (often closing down the possibility of using palliative care services) and may be inappropriate to their needs. These discussions can be held once excellent symptom control, a confiding rapport and therefore trust has been established between both parties. In rare diseases it is often preferable for palliative care clinicians to inform and support their specialist colleagues to build symptom control expertise themselves and to hold sensitive prognostic discussions initially by working alongside them. As Fallon and Foley 9 have said the wholesale transfer of palliative care approaches and extrapolation of evidence developed for cancer patients may not work for managing non-malignant disease. One clear difference being that specific anti-cancer therapy tends to be reduced as the disease advances whereas more sophisticated, less algorithmic therapeutic regimens are required with severe non-malignant disease, requiring greater disease-specific knowledge.
How can palliative care meet these huge needs practically with tightening health care budgets across the world? Fallon and Foley's 9 earlier editorial deals with the importance of cross fertilization of palliative care expertise with other specialities through stronger collaborations with trainees, and stresses the importance of our specialty being proactive and positive in forming relationships with those caring for patients with non-malignant disease. There are a growing number of specialists (particularly in nephrology, neurology 10 and respiratory medicine) who focus on patients with advanced disease; facilitating a usefully long attachment or joint working in palliative medicine would be a priority. Where we have evidence that palliative care improves outcomes, we need to make positive overtures highlighting this and not wait for referrals, actively working with key individuals who lead and fund services to make our case. The Palliative Care Outcomes Collaboration Model 11 , pioneered in Australia, is surely an excellent way ahead for the specialty.
In rare diseases and in young people we have a dearth of information and cannot assume that what we currently provide (or how we provide it) is right. We have made great strides in understanding that we need evidence to care for our patients properly, we have learned much about how we can do this more effectively, but we have only begun. It is surely indefensible that knowledge that could reduce suffering and even improve health in those who contend over many years with difficult symptoms and psychological distress remains locked up in palliative care teams until the 'diagnosis of dying' has been made.
